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ABSTRACT
Viral hepatitis poses a serious threat to mankind. Hepatitis B and C Virus are blood borne
pathogens that affect millions of individually globally. This study was conducted on a hospitalbased population in Islamabad, Pakistan over a period of 4 months, utilizing ELISA as the
diagnostic technique which suggested a higher seroprevalence rate for both HBV and HCV i.e.
2.07% and 8.24% respectively. A correlational analysis of the biochemical parameters of these
individuals with HBV and HCV infection was carried out and the results indicated a positive
correlation of HBV with Alkaline Phosphatase (ALP), HCV with Total Bilirubin (TBil) and
both the viruses with Alanine Aminotransferase (ALT). Furthermore, the risk factors in relation
to these viral infections were explored upon which our data suggested that surgery, blood
transfusion and contact with contaminated instruments at the barber for haircut/shaving and
jewelers for piercings were the major risk factors responsible for aiding the contraction of the
viral disease by patients in the hospital. These high percentages of the viral infection among
the population require proper management and prevention techniques to minimize the number
of casualties and further cases to provide a healthier surrounding for the people to live in.
Keywords: HBV, HCV, seroprevalence, biochemical investigation, risk factor.
INTRODUCTION
Hepatitis is a global health problem.
In 2017, 1.3 million people died with viral
hepatitis (Roth et al., 2018). Liver
inflammation is a lethal hepatic
abnormality caused due to either viral or
non-viral factors that tends to progress
towards cirrhosis and hepatocellular
carcinoma (HCC) (Karim et al., 2015; Zhu
et al., 2008). Hepatitis B & C Viruses are
blood borne pathogens belonging to family
Hepadnaviridae
and
Flaviviradae,
containing dsDNA with genome of 3.2 kb
and ssRNA with genome of 9.6 kb
respectively (Seeger and Mason, 2000;
Torres et al., 2013; Catanese et al., 2013).
Both HBV and HCV show great tropism
towards hepatocytes. Globally, the chronic
infection rate observed for HBV and HCV
is 257 million and 150 million respectively
with a mortality rate of 720,000 was

observed owing to cirrhosis and 470,000
due
to
hepatocellular
carcinoma
collectively caused by HBV and HCV
(Alam et al., 2007; Schweitzer et al., 2015;
World Health Organization, 2017).
Despite
the
availability
of
immunogenic, anti-viral and effective
vaccines (for HBV), statistics show that
350-400 million people are carriers of
HBV. Appropriate clinical manifestation is
required to distinguish between HBV
infection from other hepatitis causing
viruses (World Health Organization, 2017;
Datta et al., 2012). Different molecular and
routinely performed serological assays like
PCR, qPCR, Competitive PCR, ICT and
ELISA are used for the quantification of
HBV and HCV (Aguiar et al., 2014;
Pawlotsky et al., 2002; Lok and McMahon
2007; Rahman et al., 2008).
Along
with
molecular
and
serological methods different biochemical
10
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markers are involved to determine hepatic
function in case of hepatitis. Among these
marker ALT, AST, ALP, albumin and
bilirubin are considered vital for the
assessment of hepatic function in the blood
of infected individual (Chen et al., 2014;
Pattullo, 2015; Sharif et al.,2016;
Locasciulli et al., 1993; El-Kady et al.,
2017). It was noted that in chronic liver
infection, the level of ALT increased due to
parenchymal hepatic cell damage and
excessive leakage of the enzyme into blood
stream was observed. In patients with
untreated chronic infection, the increase of
ALT levels up to 400UI/L was observed
(Olut et al., 2007; Mohamadnejad et al.,
2003; Khan et al., 2016). Another important
biochemical
marker
involved
in
metabolism
and
transportation
of
metabolites across the membranes is ALP.
Studies show that the cholestatic liver
diseases cause more release of this enzyme
and increase serum ALP level in chronic
hepatitis (Pattullo, 2015; Sleisenger et al.,
1998; Whitehead et al., 1999). The level of
these biochemical markers on individual
basis or in combination help to determine
the hepatic function in viral hepatic
diseases.
It has been observed through
different studies that multiple risk factors
are involved in the viral transmission.
Different factors like mother’s age, number
of pregnancies, repeated injection,
addiction and history of blood transfusion
could be involved in vertical transmission
of hepatitis B & C from mother to infant
(Mehnaz et al., 2002; Fauteux-Daniel et al.,
2017). Risk factors which are the main
source of hepatitis transmission include
blood transfusion/transmission, dialysis,
reuse of needles for ear and nose piercing,
reuse of syringes, tattooing, shaving/cuts
from barbers and the usage of unsterilized
dental and surgical instruments (Idrees et
al., 2011; Bukhari et al., 1999; Waheed et
al., 2009). Intravenous drug abuse is also
considered to be one of the most pivotal risk
factors for causing Hepatitis B or C

infection (Kazi et al., 2010; Fayyaz et al.,
2006; Chen and Morgan, 2006).
Pakistan is a developing country
with low investments on health It has been
estimated that approximately 32% of the
Pakistani population is exposed to HBV
with 2-4% chronic HBV prevalence rate
and 10% of the population suffers from
HCV infection with approximately 4.58.2% seroprevalence in adult population
(Khan et al., 2011; Waheed et al., 2018;
Iqbal et al., 2014; Umer and Iqbal 2016).
There is a strong need to do
research on hepatitis B and C in Pakistan.
The purpose of the present study was to find
the seroprevalence of HBV and HCV
infections among the population of twin
cities, the risk factors associated with these
viral infections and to find the correlation
between Hepatitis B and C Sero-positivity
with
commonly
measured
liver
biochemical markers.
MATERIALS AND METHOD
Sample Collection and Processing
A total of 1977 blood samples were
collected from Capital Development
Authority (CDA) Hospital Islamabad from
June-October 2018. Blood (3-5 ml) was
collected via venipuncture technique and
stored in vacutainer tubes with clot
activator to produce serum upon
centrifugation.
The
samples
were
centrifuged right after collection at 5000
rpm for 5 min to obtain serum which was
then separated using filter tips. Each serum
sample was divided into two parts each for
both serological and biochemical testing.
Serological Testing
The
serum
samples
were
qualitatively tested against HBsAg
(Hepatitis B surface antigen) and AntiHCV antibodies through rapid diagnostic
test i.e. Immunochromatographic test (ICT)
followed by ELISA-based confirmation
automated Vitros®Eciq Immunodiagnostic
Analyzer Biochemical Analysis. For
11
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quantification of liver specific enzymes,
centrifuged serum samples of HBV and
HCV screened patients were subjected to
Liver function tests (LFTs) and Renal
function tests (RFTs). Biochemical analysis
was performed in Selectra XL analyzer.
Data Analysis

female. Whereas the patients screened for
HCV were 45.22% male and 54.77%
female. The data suggests that 2.7% of the
males and 1.3% of the females were
positive for HBV infection. Whereas 7.24%
males and 9.04% females were positive for
anti-HCV antibodies in their serum (Figure
2).

To find an association between
HBV and HCV serological positivity with
liver enzyme abnormalities, Pearson`s
correlation test was run, where the (p-value)
less than 0.05 with confidence interval of
95%
was
considered
statistically
significant.
RESULTS
Seroprevalence of HBV and HCV Based
on ELISA
Serum from the blood samples of
1977 patients was initially screened by ICT
method followed by confirmation with
enzyme-linked immunosorbent assay
(ELISA) for the detection of HBsAg and
anti-HCV antibodies. The results revealed
that 40/1977 (2.07%) patients tested
positive for Hepatitis B Virus and 163/1977
(8.24%) of the patients tested positive for
Hepatitis C Virus in their serum (Figure 1).

Figure 2: Gender based Seroprevalence of HBV
and HCV.

Age-Wise Distribution of HBV and HCV
Infection
The patients who tested positive for
HBV or HCV in their serum were divided
into seven age groups. The minimum age
group was kept at <20 years and the
maximum was kept at >70 years. The rate
of infection was seen to be the highest
among the individuals from the age group
61-70 years. Based on this data, a range of
age-wise frequency distribution has been
shown in Figure 3.

Figure 1: Seroprevalence of HBV and HCV
among hospital-based patients.

Gender-Wise Distribution of HBV and
HCV Infection
Out of the 1977 patients subjected
to screening for HBV and HCV, 50.32% of
the patients were male and 49.67% were
12
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among the Hepatitis C Virus infected
individuals was general surgery (Figure 4).
Fig.4: Risk factors observed among the positive
patients of HBV and HCV.

Figure 3: Age-wise distribution of HBV and
HCV infected patients among hospital-based
patients.

Correlational Analysis of HBV and HCV
Groups
Using Pearson Product Moment
Correlation, the relationship of the HBV
and HCV positive and negative participants
with the variables under study was
analyzed. Results of the correlational
analysis suggested that HBsAg seropostivity was significantly associated with
abnormal levels of Hepatic enzymes
(Alanine Aminotransferase) ALT and
(Alkaline Phosphatase) ALP (p<0.05)
whereas HCV sero-positivity showed a
significant and positive correlation with the
increased levels of the hepatic enzymes
ALT and Total Bilirubin (p<0.05) (Table
1).
Risk Factor Analysis
In the study sample, the patients
who tested positive for HBV and HCV in
their serum showed multiple risk factors
responsible for rendering them more
susceptible to infection. Except for a few,
most of the risk factors for contracting HBV
and HCV were the same, for both the
viruses are blood-borne. The risk factors
included general surgery, dental surgery,
blood transfusion and donation, pregnancy,
tattoo formation, nose and ear piercing, cuts
from barber shop equipment etc. The
highest prevailing risk factor among the
Hepatitis B Virus infected individuals in the
sample was nose and ear piercing whereas

DISCUSSION
Prevalence
As per the findings of this study, the
seroprevalence of Hepatitis B Virus among
the patients who visited the hospital facility
of Rawalpindi-Islamabad for treatment or
diagnosis was calculated to be 2.02% and in
case of Hepatitis C Virus, it was calculated
to be 8.24%. Numerous studies have been
conducted worldwide to observe the
prevalence of hepatic viruses to resolve the
epidemiological concerns. Our results were
supported by the study conducted by Haider
et al. (2017) which showed that the
prevalence of HBsAg+ among their sample
was 2.14%. The research conducted by
Muzaffar et al. (2016) indicated the
prevalence of HCV to be 5.31% among the
population of the twin cities and other
additional studies carried out in different
regions of the country showed various
results such as Lahore (4.94%) (Anwar et
al., 2013) and Mansehra (7.0%) (Ali et al.,
2010). The difference between the
prevalence of HCV in the current study and
other respective studies mentioned above
may have occurred since data collection
and sample screening in this study was done
at a hospital facility with people visiting
either for treatment or diagnosis.
It was seen that in case of HBV
infection, the percentage of male cases was
13
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higher than female cases which is supported
by the findings of other studies (Naz et al.,
2002; Khan et al., 2011). A possible cause
for the larger percentage of males being
infected is their frequent visits to the barber
shop and direct contact with contaminated
instruments used for grooming. The
number of females who tested positive for
HCV infection was higher than males
because the patients from the gynae ward
paid more frequent visits to the hospital
facility where the data collection was
carried out.
Considering
the
age-wise
distribution of viral hepatitis cases caused
by Hepatitis B and C in the current study,
the maximum number of cases were seen in
the age group (61-70 years). This finding
was supported by the survey conducted by
(Ali et al., 2008) which showed that the
maximum number of infected individuals
were above 60 years of age. The saturation
of cases in this age group can be since old
age brings along consequences such as
weakened immune system and it can render
the individual more susceptible to
contraction of the viral disease.
Biochemical Analysis
In the current study, the
correlational analysis of viral hepatitis with
different biochemical parameters which
included ALT, ALP, Total Bilirubin and
creatinine was carried out. A positive and
significant correlation was observed
between both HBV and HCV with ALT,
where (p<.05), similar results were
obtained by other studies (Mastoi et al.,
2010; Wahib et al., 2006), where ALT
levels increased significantly among the
HCV infected patients. Also, elevation in
serum ALT levels was seen among patients
suffering from chronic hepatitis B infection
(Liaw et al., 2005). The requirement of
ALT for the synthesis reactions in the liver
are the cause for its quantity to be around
3000 times higher than the serum and this
becomes the reason for ALT to be a marker
for liver damage. When hepatocellular
injury or death is concerned, ALT seeps out

from the damaged cells in to the serum and
ultimately, it is detected upon testing (Kim
et al., 2008).
Hepatitis B Virus showed a positive
and significant correlation with ALP and
Hepatitis C Virus with Total Bilirubin,
where (p<.05). These findings were
corroborated by the research carried out by
Abulude et al. (2017), the results of which
showed elevated ALP levels among their
sample i.e. HBV positive patients. High
levels of ALP can be seen due to blockage
along the biliary tract (biliary obstruction)
or pressure build up in the liver due to
scarring which can, but do not necessarily
indicate a viral infection. A study was
carried out to investigate similar parameters
and elevated levels of Total Bilirubin were
seen among 35% of their study sample
which was infected by HCV (Wahib et al.,
2006). The results of another study by (Ijaz
et al., 2011) showed elevated levels of
bilirubin among patients infected with
Hepatitis C Virus (Genotype 4) as well.
Hyperbilirubinemia is directly related to
viral infection and the extent to which
histological injury of hepatocytes has
occurred (Thapa et al., 2007). Liver being
the detoxifying organ of the body clears
away the bilirubin produced upon
breakdown of RBCs and due to scarring, it
is unable to carry out this function and thus
bilirubin levels increase within the serum
(Limdi and Hyde, 2003).
Risk Factor Analysis
In the current study, the highest
number of HBsAg seropositive patients in
case of females were those had their ears or
nose pierced and came in contact with
contaminated instruments where as in case
of males were the patients who paid
frequent visits to the barbershops using unhygienic grooming instruments. Similar
findings were observed by other studies
(Yousfani et al., 2006; Asia et al., 2008)
where piercings were the main risk factor
for HBV transmission amongst females and
frequent trips to barber shops using
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contaminated instruments in males and
children.
The risk factors which were seen to
be highly prevalent among the HCV seropositive patients in the current study were
general surgery, blood donation &
transfusion where the individuals had direct
exposure to contaminated blood products or
surgical instruments. A previous research
corroborates the findings of this study and
reported the population of Pakistan to be at
a very high risk of developing an HCV
infection through blood and blood-borne
products due to unsafe medical procedures,
lack of awareness, weak commitment to a
safe environment, and illiteracy (Janjua et
al., 2005).
In this study, 7.97% of the pregnant
female patients tested positive for the virus
in their bloodstream. This finding was
corroborated by the study conducted by
Arshad and Ashfaq (2017) who observed
that pregnant females contributed to 4.65%
of their sample infected with the virus.
Previous studies have indicated injectable
drug users (IDUs) to be at the highest risk
of developing Viral Hepatitis (Kuo et al.,
2006; Arshad and Ashfaq, 2017). However,
the sample under study for this research
didn’t have any IDUs due to the setting
where the sample collection was done i.e.
the out-patients department (OPD) at the
Capital Development Authority (CDA)
Hospital, Islamabad.
CONCLUSION
The serological prevalence of Hepatitis B
and C virus among the population of
Rawalpindi/Islamabad who visited the
hospital for treatment or diagnosis was
high, which is an alarming situation for the
residents of the region. The age groups of
the infected patients ranged from 15 – 70
years. The individuals who were at a high
risk of acquiring the infection included
people who had undergone surgical
procedures, blood transfusions, gotten nose
and ear piercings, pregnant women and
patients undergoing dialysis. Awareness
campaigns to educate people about the

transmission of viral hepatitis and to warn
them regarding the threat it poses to
people’s lives and the lives of those living
among them must be organized. Measures
to eliminate the spread of this disease must
be taken. The biochemical markers of
Hepatitis B and C Virus in correlation with
the infection yielded results which showed
a positive and significant correlation among
three of the markers. This aspect of the
current study needs to be further
investigated for this field needs further
probing to provide the required information
for treatment and better understanding.
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